Additionally, studies have shown that HSF1-HSPB1 signaling negatively regulates erastin-induced ferroptosis in a variety of cancer cells by reducing iron-mediated production of lipid ROS (ref. 36). The gene discussed is HSPB1; the disease is cancer.